Search

everythinglearnresearchcommunity

for

Search:↓

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Cells that move well may improve hair loss treatments by entering hair follicles.

Acne necrotica can be effectively treated with topical cream and antibiotics.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

RCM and OCT are effective for diagnosing and monitoring hair-related skin diseases but lack standardized protocols and need more research.

COVID-19 can cause long-term skin problems and has changed how skin doctors work.

Dermoscopic features can help identify and differentiate types of pityriasis versicolor.

People with Collagen VI-related myopathies may often have hair loss and scalp issues.

Hair loss is common in autoimmune diseases and can be an early sign of the condition, often requiring prompt treatment to prevent permanent damage.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Skin changes during pregnancy are common, and non-invasive imaging is safe for monitoring these changes.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

A woman thought to have rosacea was actually suffering from Frontal Fibrosing Alopecia, a hair loss condition. Despite treatment, her condition didn't change, showing the importance of accurate early diagnosis.

Skin aging can be slowed down with proper care and treatments.

Chronic bacterial infections of hair follicles can cause ongoing skin inflammation.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The conclusion is that having both Frontal Fibrosing Alopecia and Discoid Lupus Erythematosus may suggest a shared immune response in certain people, and a mix of antimalarial drugs and 5-alfa-reductase inhibitors is recommended for treatment.

The document concludes that various skin conditions have specific characteristics and treatments, and highlights the importance of vitamin D in managing these dermatological issues.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Lymphatic vessels help hair follicles regenerate by interacting with stem cells.

Dermal sheath cells can help grow new hair follicles and show promise in treating hair loss.

Botulinum toxin-A may increase hair growth and reduce hair loss in men with baldness, and injecting near blood vessels can improve pain relief and last longer.

EPDS and MS might share an immune-related cause.

Myotonic dystrophy should be considered in patients with hair thinning, and genetic counseling is important.

Botulinum toxin-A injections in the scalp can reduce hair loss and promote new hair growth in men with certain types of baldness.

Botulinum toxin injections can reduce hair loss and stimulate new hair growth in some men with male pattern baldness.

New insights show Lichen Planopilaris is a rare, scarring hair loss condition, hard to treat, mainly affecting middle-aged women, and significantly impacts mental health.

Using dermoscopy to guide scalp biopsies is an effective way to diagnose cicatricial alopecia.